ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01055522
Recruitment Status : Terminated
First Posted : January 25, 2010
Last Update Posted : February 25, 2014
Sponsor:
Collaborator:
Eudax S.r.l.
Information provided by (Responsible Party):
Philogen S.p.A.